⚕ GalenOps CRO console
← 708 (USA)

708-1296

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 708 (USA) (Dr. Kim) · consented 2013-06-14
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-04 (study day 83.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-09-04 (study day 83.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-04 (study day 113.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE VESICLES — outcome: RECOVERED/RESOLVED; onset 2013-10-04 (study day 113.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild ATRIAL HYPERTROPHY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-27 (study day 14.0); relationship: REMOTE

mild assessed 2026-08-18

Mild ATRIAL HYPERTROPHY — outcome: RECOVERED/RESOLVED; onset 2013-06-27 (study day 14.0); relationship: REMOTE

mild assessed 2026-08-18

Mild PAIN IN EXTREMITY — outcome: RECOVERED/RESOLVED; onset 2013-12-07 (study day 177.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.